Noah Berkowitz
Vermogen: 2 M $ op 31-08-2026
Vermogen: 2 M $ op 31-08-2026
Noah Berkowitz is the founder of Physician's Choice, Inc. Currently, Dr. Berkowitz is President & Chief Executive Officer at HaptoGuard, Inc. Formerly, Dr. Berkowitz was Chief Medical Officer at Arvinas, Inc. from 2024 to 2026, President, Chief Executive Officer & Secretary at Synvista Therapeutics, Inc. from 2006 to 2012, Director at Poseida Therapeutics, Inc., Vice President-Clinical Development at IMPATH, Inc., Consultant at Predix Pharmaceuticals, Inc., Consultant at Teva Pharmaceuticals USA, Inc., and Senior Vice President & Head-Hematology at Bristol Myers Squibb Co. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARVINAS, INC. 0,29% | 11-05-2026 | 191.395 ( 0,29% ) | 2 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ARVINAS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-07-2026 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| POSEIDA THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Hoofd Techniek/Wetenschap/O&O | - |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Synvista Therapeutics, Inc.
Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Health Services |
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physician's Choice, Inc.
Physician's Choice, Inc. Internet Software/ServicesTechnology Services Provides postclinical, premarketing, cost-benefit analysis to biotech companies | Technology Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau